Clinical Study
Comparison of Clinical Outcomes Using “Elevate Anterior” versus “Perigee” System Devices for the Treatment of Pelvic Organ Prolapse
Table 4
Urodynamic changes in both groups before and 6 months after surgery. Data are given as
(%) or mean ± standard deviation.
| Parameters | Perigee ( = 91) | Elevate ( = 50) | Pre-op | Post-op | value | Pre-op | Post-op | value |
| DO | 31 (34.1) | 12 (13.2) | 0.002 | 17 (34.0) | 11 (22.0) | 0.29 | Qmax (mL/s) | 18.6 ± 9.0 | 19.6 ± 10.2 | 0.26 | 21.0 ± 14.3 | 18.0 ± 8.9 | 0.06 | RU (mL) | 63.1 ± 45.3 | 32.8 ± 32.7 | 0.015 | 71.3 ± 50.3 | 36.6 ± 22.6 | 0.038 | FS (mL) | 164.6 ± 73.9 | 154.5 ± 64.3 | 0.23 | 135.7 ± 54.9 | 133.0 ± 59.5 | 0.79 | MCC (mL) | 409.5 ± 127.0 | 400.7 ± 111.4 | 0.35 | 332.5 ± 81.1 | 324.8 ± 109.4 | 0.57 | Pdet (cmH2O) | 26.5 ± 19.9 | 28.0 ± 17.9 | 0.52 | 19.5 ± 7.6 | 18.6 ± 11.0 | 0.68 | FUL (mm) | 24.6 ± 6.1 | 27.1 ± 4.9 | 0.07 | 27.8 ± 7.1 | 25.4 ± 8.4 | 0.14 | MUCP (cmH2O) | 56.3 ± 26.2 | 63.1 ± 34.2 | 0.25 | 73.0 ± 29.5 | 72.5 ± 24.9 | 0.90 | UCA (mmcmH2O) | 730.3 ± 456.9 | 816.5 ± 408.3 | 0.12 | 1012.6 ± 396.8 | 934.4 ± 391.8 | 0.11 |
|
|
DO, detrusor overactivity; Qmax, maximum flow rate; RU, residual urine; FS, first sensation to void; MCC, maximum cystometric capacity; Pdet, detrusor pressure at peak flow; FUL, functional urethral length; MUCP, maximum urethral closure pressure; UCA, urethral closure area. McNemar’s test; Paired -test. ∧Statistical significance.
|